发明申请
US20110130423A1 Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine
失效
在M1受体中具有活性的化合物及其在医学中的用途
- 专利标题： Compounds Which Have Activity At M1 Receptor And Their Uses In Medicine
- 专利标题（中）： 在M1受体中具有活性的化合物及其在医学中的用途
-
申请号： US12678360申请日： 2008-09-18
-
公开(公告)号： US20110130423A1公开(公告)日： 2011-06-02
- 发明人: David Gwyn Cooper , Ian Thomas Forbes , Vincenzo Garzya , Dale James Johnson , Paul Adrian Wyman
- 申请人： David Gwyn Cooper , Ian Thomas Forbes , Vincenzo Garzya , Dale James Johnson , Paul Adrian Wyman
- 专利权人： Glaxo Group Limited,
- 当前专利权人： Glaxo Group Limited,
- 优先权： GB0718415.3 20070920
- 国际申请： PCT/EP08/62398 WO 20080918
- 主分类号： A61K31/454
- IPC分类号： A61K31/454 ; C07D401/14 ; A61P25/18 ; A61P25/28
摘要：
Compounds of formula (I) and salts thereof are provided: wherein R4, R5, R6, Q, A, and Y are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.